Ocugen, Inc. (OCGN)
0.7658
+0.06
(+8.10%)
USD |
NASDAQ |
Oct 27, 16:00
0.7654
0.00 (0.00%)
After-Hours: 20:00
Ocugen Price : 0.7658 for Oct. 27, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 26, 2026 | 0.7402 | 0.75 | 0.7016 | 0.7084 | 8.310M |
| Oct 23, 2026 | 0.7950 | 0.7950 | 0.732 | 0.7397 | 8.585M |
| Oct 22, 2026 | 0.80 | 0.835 | 0.79 | 0.79 | 6.719M |
| Oct 21, 2026 | 0.8256 | 0.83 | 0.7906 | 0.8151 | 4.322M |
| Oct 20, 2026 | 0.79 | 0.84 | 0.786 | 0.8125 | 6.662M |
| Oct 19, 2026 | 0.8025 | 0.8149 | 0.782 | 0.7873 | 4.471M |
| Oct 16, 2026 | 0.84 | 0.84 | 0.7803 | 0.7803 | 5.147M |
| Oct 15, 2026 | 0.8401 | 0.85 | 0.79 | 0.8137 | 5.936M |
| Oct 14, 2026 | 0.888 | 0.9197 | 0.785 | 0.8412 | 9.534M |
| Oct 13, 2026 | 0.9454 | 0.9454 | 0.87 | 0.8854 | 6.890M |
| Oct 12, 2026 | 0.9573 | 0.9805 | 0.924 | 0.9472 | 3.271M |
| Oct 09, 2026 | 0.9739 | 0.9955 | 0.9001 | 0.9555 | 13.34M |
| Oct 08, 2026 | 1.01 | 1.01 | 0.9601 | 0.9774 | 12.02M |
| Oct 07, 2026 | 1.04 | 1.05 | 1.00 | 1.00 | 5.221M |
| Oct 06, 2026 | 1.05 | 1.12 | 1.04 | 1.04 | 5.294M |
| Oct 05, 2026 | 1.03 | 1.05 | 1.00 | 1.04 | 5.496M |
| Oct 02, 2026 | 1.04 | 1.04 | 1.01 | 1.02 | 3.447M |
| Oct 01, 2026 | 1.03 | 1.05 | 1.00 | 1.00 | 5.058M |
| Sep 30, 2026 | 1.09 | 1.10 | 1.01 | 1.03 | 7.323M |
| Sep 29, 2026 | 1.05 | 1.10 | 1.04 | 1.09 | 7.556M |
| Sep 28, 2026 | 1.025 | 1.05 | 1.00 | 1.03 | 4.860M |
| Sep 25, 2026 | 1.06 | 1.09 | 1.015 | 1.02 | 8.695M |
| Sep 24, 2026 | 0.9965 | 1.02 | 0.9701 | 1.00 | 5.622M |
| Sep 23, 2026 | 1.06 | 1.06 | 0.9816 | 1.00 | 12.17M |
| Sep 22, 2026 | 1.05 | 1.08 | 1.03 | 1.04 | 5.713M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 20.16 |
| Anika Therapeutics, Inc. | 21.28 |
| Gilead Sciences, Inc. | 159.08 |
| MannKind Corp. | 3.295 |
| Nektar Therapeutics | 37.97 |
Price Related Metrics
| PS Ratio | 53.61 |
| PEG Ratio | -0.1036 |
| Earnings Yield | -33.26% |
| Market Cap | 259.64M |
| PEGY Ratio | -0.1036 |